Poniard Pharmaceuticals Inc

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

25 documents for Poniard Pharmaceuticals Inc

- Merriman Curhan Ford Initiates Coverage on Celgene Corporation, Cinemark Holdings Inc., Poniard Pharmaceuticals, Inc. and VIVUS Inc.
SAN FRANCISCO -- Merriman Curhan Ford (NASDAQ: MERR) initiated equity research coverage today on Celgene Corporation (NASDAQ: CELG), Cinemark Holdings...
- Business Wire
- July 28, 2009
- Self-Regulatory Organizations; Proposed Rule Changes: International Securities Exchange, LLC
...BCRX............... BioCryst Pharmaceuticals Inc. BK................ Bank of New York Mellon Co...PARD............... Poniard Pharmaceuticals Inc. PEP................ PepsiCo I...
- FR, February 09, 2010
- Notices
- Securities and Exchange Commission
- PicksThatMove.com Announces Investment Opinion on Poniard Pharmaceuticals Inc., Vantage Drilling Co., Uranium One Inc., On2 Technologies Inc. and Vital Products Inc.
CALGARY, Alberta -- The investment opinions offered below and in this press release are provided by Nick Hunter, RIA, of PicksThatMove.com. PicksTha...
- Business Wire
- January 23, 2010

- Research and Markets: Ovarian Cancer - Pipeline Review, Q1 2011 Reviews Key Players Involved In the Therapeutic Development for Ovarian Cancer.
...* Sigma-Tau S.p.A. * Sunesis Pharmaceuticals, Inc. * ChemGenex Pharmaceuticals Limited. * Oncol...* CytRx Corporation. * Poniard Pharmaceuticals, Inc. * Regeneron Pharmaceuticals,...
- Business Wire
- February 10, 2011
- PONIARD PHARMACEUTICALS REPORTS 2ND QTR NET LOSS OF $8.5 MIL.
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, has reported on its corporate progress and financial re...
- Biotech Financial Reports
- Vol. 14 Nbr. 9, September 2007
- Self-Regulatory Organizations; Proposed Rule Changes: NYSE Arca, Inc.
...BCRX........ BioCryst Pharmaceuticals Inc. 158......... PARD........ Poniard. Pharmaceu...
- FR, February 10, 2010
- Notices
- Securities and Exchange Commission
- JMP Securities Healthcare Conference to Be Held in New York.
...A.D.A.M., Inc. ACADIA Pharmaceuticals Inc. Acceleron Pharma, Inc. Achillion Pharmaceutic...Pharmaxis Ltd. Pharmerica Corp. Poniard Pharmaceuticals, Inc. Presidio Pharmaceuticals, In...
- Business Wire
- October 01, 2008
- Self-Regulatory Organizations; Proposed Rule Changes: Chicago Board Options Exchange, Inc.
...BCRX........ BioCryst Pharmaceuticals Inc. PARD........ Poniard Pharmaceuticals Inc. BK....
- FR, February 10, 2010
- Notices
- Securities and Exchange Commission
- KaloBios Announces Two Significant Additions to Its Management Team.
...-- KaloBios Pharmaceuticals, Inc. today announced the appointments of two sign..., Inc., Vical Incorporated and Poniard Pharmaceuticals. Mr. Lyons holds a B.S. degree in ...
- Business Wire
- March 17, 2011
- Self-Regulatory Organizations; Proposed Rule Changes: NASDAQ OMX BX, Inc.
...BCRX................ BioCryst Pharmaceuticals PARD.......... Poniard Pharmaceuticals. Inc. Inc.\...
- FR, February 08, 2010
- Notices
- Securities and Exchange Commission